<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
<journal-title-group>
<journal-title>Nature Communications</journal-title>
</journal-title-group>
<issn pub-type="epub">2041-1723</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29295991</article-id>
<article-id pub-id-type="pmc">5750227</article-id>
<article-id pub-id-type="publisher-id">2416</article-id>
<article-id pub-id-type="doi">10.1038/s41467-017-02416-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Network connectivity determines cortical thinning in early Parkinson’s disease progression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Yau</surname>
<given-names>Y.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zeighami</surname>
<given-names>Y.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>T. E.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Larcher</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9375-9520</contrib-id>
<name>
<surname>Vainik</surname>
<given-names>U.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dadar</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fonov</surname>
<given-names>V. S.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagmann</surname>
<given-names>P.</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Griffa</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mišić</surname>
<given-names>B.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Collins</surname>
<given-names>D. L.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0945-5779</contrib-id>
<name>
<surname>Dagher</surname>
<given-names>A.</given-names>
</name>
<address>
<email>alain.dagher@mcgill.ca</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution>Montreal Neurological Institute, </institution><institution>McGill University, </institution></institution-wrap>3801 University Street, Montreal, QC H3A 2B4 Canada </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8796</institution-id><institution-id institution-id-type="GRID">grid.430387.b</institution-id><institution>Center for Molecular and Behavioral Neuroscience, </institution><institution>Rutgers University, </institution></institution-wrap>197 University Avenue, Newark, NJ 07102 USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0943 7661</institution-id><institution-id institution-id-type="GRID">grid.10939.32</institution-id><institution>Institute of Psychology, Faculty of Social Sciences, </institution><institution>University of Tartu, </institution></institution-wrap>Näituse 2, 50409 Tartu, Estonia </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0423 4662</institution-id><institution-id institution-id-type="GRID">grid.8515.9</institution-id><institution>Department of Radiology, </institution><institution>Lausanne University Hospital and University of Lausanne, </institution></institution-wrap>Rue du Bugnon 21, 1011 Lausanne, Switzerland </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000000090126352</institution-id><institution-id institution-id-type="GRID">grid.7692.a</institution-id><institution>Brain Center Rudolf Magnus, </institution><institution>UMC Utrecht, </institution></institution-wrap>Heidelberglaan 100, A01.126, 3508 GA Utrecht, The Netherlands </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>2</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>12</elocation-id>
<history>
<date date-type="received">
<day>6</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Here we test the hypothesis that the neurodegenerative process in Parkinson’s disease (PD) moves stereotypically along neural networks, possibly reflecting the spread of toxic alpha-synuclein molecules. PD patients (<italic>n</italic> = 105) and matched controls (<italic>n</italic> = 57) underwent T1-MRI at entry and 1 year later as part of the Parkinson’s Progression Markers Initiative. Over this period, PD patients demonstrate significantly greater cortical thinning than controls in parts of the left occipital and bilateral frontal lobes and right somatomotor-sensory cortex. Cortical thinning is correlated to connectivity (measured functionally or structurally) to a “disease reservoir” evaluated by MRI at baseline. The atrophy pattern in the ventral frontal lobes resembles one described in certain cases of Alzheimer’s disease. Our findings suggest that disease propagation to the cortex in PD follows neuronal connectivity and that disease spread to the cortex may herald the onset of cognitive impairment.</p>
</abstract>
<abstract abstract-type="web-summary" id="Abs2">
<p id="Par2">In Parkinson’s disease (PD), neurodegeneration spreads from the brainstem to the cerebral cortex. Here, in a longitudinal study of PD patients, the authors found that cortical thinning followed neural connectivity from a “disease reservoir”.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par3">The network-spread hypothesis proposes that neurodegenerative diseases target intrinsic brain networks. Specifically, it is suggested that the progression of disease follows network connectivity and that neurotoxicity is caused by the spread and accumulation of toxic agents along the brain’s neuronal connectome<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. In the case of Parkinson’s disease (PD), the likely agent is misfolded α-synuclein (α-syn). In its normal conformation, α-syn is an endogenous protein that is soluble and contributes to synaptic vesicular function<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>; however, in synucleinopathies such as PD, α-syn is present in a hyperphosphorylated and insoluble state and found to adopt an abnormal configuration into amyloid fibril aggregates<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. A model first proposed by Braak suggested that patterns of abnormal α-syn accumulation observed at postmortem were consistent with a stereotyped propagation from brainstem to subcortical areas to cortex, which paralleled the clinical progression of the disease<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Numerous lines of evidence support this model: misfolded α-syn aggregates are identified at postmortem in the brains of PD patients, and the protein has been shown to spread through neuroanatomical pathways causing cell death in animal models due to its neurotoxicity<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>; however, the model remains controversial and direct human evidence is sparse<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>.</p>
<p id="Par4">There is currently no imaging technique that allows in vivo measurement of α-syn in the brain. However, we previously observed a pattern of brain atrophy in cross-sectional magnetic resonance imaging (MRI) scans of de novo PD patients from the Parkinson’s Progression Markers Initiative (PPMI) database<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> that was consistent with the network-spread hypothesis<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. The regional distribution of atrophy identified using deformation-based morphometry (DBM) overlapped with an intrinsic connectivity network, and the pattern suggested a disease epicenter in the substantia nigra. The atrophy distribution was mostly subcortical, involving brainstem, striatum, thalamus, and medial temporal lobe.</p>
<p id="Par5">Recent studies using voxel-based morphometry (VBM) to assess gray matter density have begun to highlight a pattern of cortical changes in PD<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>, but there have been discrepant findings<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. Inconsistencies are not only due to heterogeneity in disease progression and small sample sizes, but also to methodological issues<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Cortical thickness analysis may be better able to delineate cortical morphometrical patterns and may be more sensitive to age or disease-related regional gray matter changes than VBM<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. While cortical thinning is normal in the aging process<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, deviations from typical patterns can be used as diagnostic indicators for neurodegenerative disorders (e.g., Alzheimer’s disease (AD)) even at early stages<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Several cross-sectional studies of MRI-derived cortical thickness in early-stage PD have reported cortical thinning in parietal and premotor regions compared to controls<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref></sup>. Moreover, cortical thinning appears to correlate with poorer cognitive performance<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. However, cortical thickness in PD has yet to be studied in a controlled longitudinal setting, and little is known as to how it may correlate with other disease-related measures.</p>
<p id="Par6">Disease spread to cortical areas may be accompanied by the start of cognitive impairment. Dementia is now recognized as a common, perhaps inevitable, feature of PD<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. Cognitive impairment takes several forms, starting with executive (frontal lobe) dysfunction and apathy, and progressing to visual hallucinations, impulse control, and behavioral disorders, and, eventually, a global cognitive impairment that resembles AD<sup><xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR27">27</xref></sup>. As with the classical dementias, it is likely that the specific pattern of disease spread in PD may shape the clinical features of the dementing process<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>.</p>
<p id="Par7">Here we take advantage of follow-up imaging in a large longitudinal, multicenter study that aimed to assess the progression of clinical features, imaging, and other biomarkers in a cohort of well-characterized de novo PD patients. Using the PPMI database (<ext-link ext-link-type="uri" xlink:href="http://www.ppmi-info.org/data">http://www.ppmi-info.org/data</ext-link>), we test the theory that disease progression at a 1-year follow-up, as assessed by cortical thickness, is best explained by spread from a “disease reservoir” along the brain’s connectome. We further identify certain factors at baseline that predict severity of disease progression at follow-up and provide evidence that cortical involvement might herald the onset of cognitive decline.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>Results</title>
<sec id="Sec3">
<title>Participants</title>
<p id="Par8">Participants in the present study consisted of de novo PD patients (<italic>n</italic> = 105) and healthy controls (HC, <italic>n</italic> = 57) enrolled in the PPMI study<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> [accessed May 01, 2016), clinicaltrials.gov identifier NCT01141023] who had follow-up assessment 1-year postenrollment (1.05 years for both groups). Demographic and clinical data are summarized in Table <xref ref-type="table" rid="Tab1">1</xref>. PD patients were unmedicated at the first evaluation. At 1-year follow-up, 81 of the 105 were on PD medication (e.g., levodopa or dopamine agonist). Among PD patients, performance on the Montreal Cognitive Assessment (MoCA) was slightly worse at follow-up compared to baseline (from 27.5 to 26.7, <italic>t</italic>(103) = 3.038, <italic>p</italic> = 0.003). PD patients also scored higher on the Movement Disorders Society Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) at follow-up compared to baseline, but this did not reach statistical significance (from 21.7 to 23.1, <italic>t</italic>(95) = −1.544, <italic>p</italic> = 0.126).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic, clinical, and laboratory measures</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>
<bold>PD patients</bold>
</th><th>
<bold>Healthy controls</bold>
</th><th>
<bold><italic>t</italic></bold>
<bold>-test/</bold>
<bold><italic>χ</italic></bold>
<sup><bold>2</bold></sup>
</th><th>
<bold><italic>p</italic></bold>
<bold>-value</bold>
</th></tr></thead><tbody><tr><td colspan="5">Age</td></tr><tr><td>
<italic>t</italic>
<sub>1</sub>
</td><td>61.06 ± 9.37</td><td>59.05 ± 10.96</td><td>1.224</td><td>0.223</td></tr><tr><td>
<italic>t</italic>
<sub>2</sub>
</td><td>62.11 ± 9.37</td><td>60.10 ± 10.96</td><td>1.223</td><td>0.223</td></tr><tr><td> Sex</td><td>33 F: 72 M</td><td>22 F: 35 M</td><td>0.846</td><td>0.358</td></tr><tr><td colspan="5">UPDRS-III</td></tr><tr><td>
<italic>t</italic>
<sub>1</sub>
</td><td>21.67 ± 9.61</td><td>—</td><td>—</td><td>—</td></tr><tr><td>
<italic>t</italic>
<sub>2</sub>
</td><td>23.10 ± 10.67</td><td>—</td><td>—</td><td>—</td></tr><tr><td colspan="5">MoCA</td></tr><tr><td>
<italic>t</italic>
<sub>1</sub>
</td><td>27.49 ± 2.11</td><td>28.30 ± 1.13</td><td>−3.162</td><td>0.002</td></tr><tr><td>
<italic>t</italic>
<sub>2</sub>
</td><td>26.67 ± 2.78</td><td>27.35 ± 2.01</td><td>−1.778</td><td>0.077</td></tr><tr><td colspan="5">α-syn</td></tr><tr><td>
<italic>t</italic>
<sub>1</sub>
</td><td>1841.54 ± 729.73</td><td>1898.84 ± 753.12</td><td>−0.462</td><td>0.645</td></tr><tr><td colspan="5">Aβ42</td></tr><tr><td>
<italic>t</italic>
<sub>1</sub>
</td><td>370.33 ± 97.02</td><td>373.36 ± 92.53</td><td>−0.189</td><td>0.850</td></tr><tr><td colspan="5">t-tau</td></tr><tr><td>
<italic>t</italic>
<sub>1</sub>
</td><td>44.77 ± 18.36</td><td>46.06 ± 19.69</td><td>−0.407</td><td>0.684</td></tr><tr><td colspan="5">p-tau<sub>181</sub>
</td></tr><tr><td>
<italic>t</italic>
<sub>1</sub>
</td><td>15.85 ± 9.74</td><td>17.30 ± 9.84</td><td>−0.885</td><td>0.377</td></tr></tbody></table><table-wrap-foot><p>
<italic>t</italic>
<sub>1</sub> measures at entry, <italic>t</italic>
<sub>2</sub> measures at 1-year follow-up. Values are expressed as mean ± standard deviation. Two rightmost columns refer to the difference between PD and controls. All cerebrospinal fluid measures are expressed in pg/ml</p><p>
<italic>UPDRS-III</italic> Movement Disorders Society Unified Parkinson’s Disease Rating Scale Part III, <italic>MoCA</italic> Montreal Cognitive Assessment, <italic>α-syn</italic> α-synuclein, <italic>Aβ42</italic> β-amyloid 1–42, <italic>t-tau</italic> total tau, <italic>p-tau</italic>
<sub><italic>181</italic></sub> phosphorylated tau</p></table-wrap-foot></table-wrap>
</p>
</sec>
<sec id="Sec4">
<title>Changes in cortical thickness at 1-year follow-up</title>
<p id="Par9">Over the 1-year period, mean whole-brain cortical thickness significantly decreased among both PD patients (<italic>t</italic>
<sub>1</sub> = 3.055 mm ± 0.013; <italic>t</italic>
<sub>2</sub> = 3.027 mm ± 0.013) and controls (<italic>t</italic>
<sub>1</sub> = 3.055 mm ± 0.016; <italic>t</italic>
<sub>2</sub> = 3.036 mm ± 0.017) (both <italic>p</italic> &lt; 0.01). Regional cortical thinning was greater in PD than HC (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Specifically, four significant clusters were identified: (1) left occipital and inferior and middle temporal gyri, (2) left frontal, (3) right frontal, and (4) right pre- and post-central gyrus and supramarginal gyrus (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). The frontal lobe atrophy mostly involved the inferior parts of lateral and medial frontal cortex, including the orbitofrontal cortex, frontal pole, ventromedial, and rostral dorsomedial prefrontal cortex. On the lateral surface, inferior and medial frontal gyri were implicated, with extension to the superior frontal gyrus on the left. In order to assess the likely functional consequences of cortical thinning in PD, we assigned each cortical parcel to one of the seven intrinsic brain networks derived from resting-state functionl MRI (fMRI) by Yeo et al.<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Cortical regions belonging to the limbic, frontoparietal, and ventral attention networks on average demonstrated the greatest cortical thinning, as well as anterior parts of the default mode network (DMN; Fig. <xref ref-type="fig" rid="Fig3">3</xref>). There were no areas showing greater loss of cortical thickness in HC than in PD.<fig id="Fig1"><label>Fig. 1</label><caption><p>Cortical thinning in PD. Changes in cortical thickness in PD patients compared to healthy controls over the 1-year study period. Left panel: <italic>t</italic>-statistic comparing PD to HC at baseline and follow-up [(PD2-PD1)–(HC2-HC1)], at each cortical vertex. Right panel: thresholded map showing areas of significant difference. Cluster-corrected <italic>p</italic>-value in blue</p></caption><graphic id="d29e919" xlink:href="41467_2017_2416_Fig1_HTML"></graphic></fig>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Significant clusters of cortical thinning in PD. Four peak clusters of cortical thinning in PD were identified in parts of (1) left occipital lobe (nverts = 1081 [5.53 resels], <italic>p</italic> &lt; 0.0001, (2) left frontal lobe (nverts = 2115 [10.99 resels], <italic>p</italic> &lt; 0.0001), (3) right frontal lobe (nverts = 3720 [15.79 resels], <italic>p</italic> &lt; 0.0001), and (4) right somatomotor cortex (nverts = 1990 [16.56 resels], <italic>p</italic> &lt; 0.0001). nverts: number of vertices in the significant area</p></caption><graphic id="d29e941" xlink:href="41467_2017_2416_Fig2_HTML"></graphic></fig>
<fig id="Fig3"><label>Fig. 3</label><caption><p>Intrinsic networks affected by cortical thinning. Cortical thinning in PD vs HC in the seven intrinsic brain networks of Yeo et al.<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. All seven intrinsic brain networks demonstrated significant cortical thinning with <italic>p</italic> &lt; 0.0001 (permutation test <italic>n</italic> = 10,000): visual network (<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{\mu }} = 0.63;95{\mathrm{\% }}\;{\mathrm{CI}} \in [0.46,0.81]$$\end{document}</tex-math><mml:math id="M2"><mml:mi mathvariant="normal">μ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.63</mml:mn><mml:mo>;</mml:mo><mml:mn>95</mml:mn><mml:mi mathvariant="normal">%</mml:mi><mml:mspace width="2.77626pt"></mml:mspace><mml:mi mathvariant="normal">CI</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.46</mml:mn><mml:mo>,</mml:mo><mml:mn>0.81</mml:mn></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2017_2416_Article_IEq1.gif"></inline-graphic></alternatives></inline-formula>), somatomotor network (<inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{\mu }} = 0.53;95{\mathrm{\% }}\;{\mathrm{CI}} \in [0.37,0.69]$$\end{document}</tex-math><mml:math id="M4"><mml:mi mathvariant="normal">μ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.53</mml:mn><mml:mo>;</mml:mo><mml:mn>95</mml:mn><mml:mi mathvariant="normal">%</mml:mi><mml:mspace width="2.77626pt"></mml:mspace><mml:mi mathvariant="normal">CI</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.37</mml:mn><mml:mo>,</mml:mo><mml:mn>0.69</mml:mn></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2017_2416_Article_IEq2.gif"></inline-graphic></alternatives></inline-formula>), dorsal attention network (<inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{\mu }} = 0.52;95{\mathrm{\% }}\;{\mathrm{CI}} \in [0.32,0.73]$$\end{document}</tex-math><mml:math id="M6"><mml:mi mathvariant="normal">μ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.52</mml:mn><mml:mo>;</mml:mo><mml:mn>95</mml:mn><mml:mi mathvariant="normal">%</mml:mi><mml:mspace width="2.77626pt"></mml:mspace><mml:mi mathvariant="normal">CI</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.32</mml:mn><mml:mo>,</mml:mo><mml:mn>0.73</mml:mn></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2017_2416_Article_IEq3.gif"></inline-graphic></alternatives></inline-formula>), ventral attention network (<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{\mu }} = 0.86;95{\mathrm{\% }}\;{\mathrm{CI}} \in [0.67,1.94]$$\end{document}</tex-math><mml:math id="M8"><mml:mi mathvariant="normal">μ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.86</mml:mn><mml:mo>;</mml:mo><mml:mn>95</mml:mn><mml:mi mathvariant="normal">%</mml:mi><mml:mspace width="2.77626pt"></mml:mspace><mml:mi mathvariant="normal">CI</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.67</mml:mn><mml:mo>,</mml:mo><mml:mn>1.94</mml:mn></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2017_2416_Article_IEq4.gif"></inline-graphic></alternatives></inline-formula>), limbic network (<inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{\mu }} = 1.2;95{\mathrm{\% }}\;{\mathrm{CI}} \in [0.98,1.40]$$\end{document}</tex-math><mml:math id="M10"><mml:mi mathvariant="normal">μ</mml:mi><mml:mo>=</mml:mo><mml:mn>1.2</mml:mn><mml:mo>;</mml:mo><mml:mn>95</mml:mn><mml:mi mathvariant="normal">%</mml:mi><mml:mspace width="2.77626pt"></mml:mspace><mml:mi mathvariant="normal">CI</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.98</mml:mn><mml:mo>,</mml:mo><mml:mn>1.40</mml:mn></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2017_2416_Article_IEq5.gif"></inline-graphic></alternatives></inline-formula>), frontoparietal network (<inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{\mu }} = 1.05;95{\mathrm{\% }}\;{\mathrm{CI}} \in [0.80,1.28]$$\end{document}</tex-math><mml:math id="M12"><mml:mi mathvariant="normal">μ</mml:mi><mml:mo>=</mml:mo><mml:mn>1.05</mml:mn><mml:mo>;</mml:mo><mml:mn>95</mml:mn><mml:mi mathvariant="normal">%</mml:mi><mml:mspace width="2.77626pt"></mml:mspace><mml:mi mathvariant="normal">CI</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.80</mml:mn><mml:mo>,</mml:mo><mml:mn>1.28</mml:mn></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2017_2416_Article_IEq6.gif"></inline-graphic></alternatives></inline-formula>), and default mode network (<inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{\mu }} = 0.73;95{\mathrm{\% }}\;{\mathrm{CI}} \in [0.57,0.88]$$\end{document}</tex-math><mml:math id="M14"><mml:mi mathvariant="normal">μ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.73</mml:mn><mml:mo>;</mml:mo><mml:mn>95</mml:mn><mml:mi mathvariant="normal">%</mml:mi><mml:mspace width="2.77626pt"></mml:mspace><mml:mi mathvariant="normal">CI</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.57</mml:mn><mml:mo>,</mml:mo><mml:mn>0.88</mml:mn></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41467_2017_2416_Article_IEq7.gif"></inline-graphic></alternatives></inline-formula>). + outliers within each network.</p></caption><graphic id="d29e1221" xlink:href="41467_2017_2416_Fig3_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec5">
<title>Connectivity and disease propagation</title>
<p id="Par10">The disease propagation hypothesis predicts that cortical brain atrophy at follow-up should depend on connectivity of cortical areas to affected areas at baseline. We had previously shown predominant subcortical atrophy in de novo PD in this population. Connectivity between any cortical area and this putative subcortical “disease reservoir” should therefore predict the degree of cortical thinning relative to age-matched controls when comparing follow-up to baseline. We define the disease reservoir as the subcortical areas showing atrophy in PD patients relative to controls at the initial evaluation, as determined previously using DBM<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. For the current analysis, the brain was segmented into 463 cortical and subcortical regions of interest<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Each surface vertex from the cortical thickness images was mapped to the nearest volumetric parcel (see Methods section). To examine the propagation hypothesis, the connectivity (Conn<sub><italic>ij</italic></sub>) between any cortical parcel <italic>i</italic> and any parcel belonging to the disease reservoir <italic>j</italic> was measured. Here we calculated Conn<sub><italic>ij</italic></sub> based on healthy brain connectomes (see Methods section). The analysis was performed for the whole brain and for each hemisphere separately using Spearman’s correlation to examine the relation between disease progression and exposure. Disease exposure was defined as the product of connectivity and atrophy measure in the corresponding disease reservoir region <italic>j</italic> at the onset of the disease, summed over all possible connections.<disp-formula id="Equ1"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm Disease}\;{\mathrm exposure} \left( i \right) = \mathop {\sum} \limits_j {\mathrm Conn}_{ij} \cdot {\mathrm Atrophy}(j)$$\end{document}</tex-math><mml:math display="block" id="M16"><mml:mi mathvariant="normal">D</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mspace width="2.77626pt"></mml:mspace><mml:mi mathvariant="normal">e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo> ∑</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mi mathvariant="normal">A</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>h</mml:mi><mml:mi>y</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math><graphic position="anchor" xlink:href="41467_2017_2416_Article_Equ1.gif"></graphic></alternatives></disp-formula>
</p>
<p id="Par11">Both functional and structural connectivity were used to test the propagation hypothesis (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). Connectomes were generated using data from young healthy individuals to calculate the Conn<sub><italic>ij</italic></sub>. Atrophy(<italic>j</italic>) was set equal to the <italic>z</italic>-value at each region <italic>j</italic> of the independent component demonstrating atrophy in PD compared to HC from the previously computed DBM map from the baseline MRI<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Note that for areas not showing significant atrophy at baseline the value of Atrophy(<italic>j</italic>) is equal to 0.<fig id="Fig4"><label>Fig. 4</label><caption><p>Testing the propagation model. <bold>a</bold> Schematic of the propagation model. The model used a disease reservoir (colored regions) consisting of 15 subcortical regions of interest and connectivity from each region to the cortical surface. <bold>b</bold> PD-specific atrophy map used to define disease “content” in each region of interest of the disease reservoir, derived from deformation-based morphometric analysis of patients at baseline (modified from Zeighami et al. 2015). <bold>c</bold>–<bold>e</bold> Correlation between cortical thinning (average <italic>t</italic>-values, PD–HC, <italic>t</italic>
<sub>2</sub>–<italic>t</italic>
<sub>1</sub>) of each cortical region and disease exposure (see text for detail). Connectivity based on functional resting state data in the <bold>c</bold> left and <bold>d</bold> right hemisphere as well as connectivity based on diffusion-weighted data in the <bold>e</bold> left and <bold>f</bold> right hemisphere are depicted</p></caption><graphic id="d29e1422" xlink:href="41467_2017_2416_Fig4_HTML"></graphic></fig>
</p>
<p id="Par12">First, a functional connectome was generated using resting-state fMRI to define Conn<sub><italic>ij</italic></sub>. Significant correlation was observed between regional cortical thinning and disease exposure (<italic>r</italic> = 0.19, <italic>p</italic> &lt; 0.0001). Significance was confirmed by permutation testing where we kept the connectivity structure (i.e., subcortical–cortical connections) intact and permuted the cortical thinning values (<italic>n</italic> = 10,000) and the 95% confidence interval was measured using bootstrapping (<italic>n</italic> = 10,000) (<italic>r</italic> ∈ [0.11,0.28], <italic>p</italic>_perm &lt; 0.0001). Moreover, cortical thickness of both the left (<italic>r</italic> = 0.22, <italic>p</italic> = 0.0005, <italic>r</italic> ∈ [0.09,0.34], <italic>p</italic>_perm = 0.0004) and right hemisphere (<italic>r</italic> = 0.27, <italic>p</italic> &lt; 0.0001, <italic>r</italic> ∈ [0.16,0.38], <italic>p</italic>_perm &lt; 0.0001) significantly correlated with the disease exposure from bilateral affected regions.</p>
<p id="Par13">Second, the same hypothesis was tested using structural connectivity as measured by diffusion-weighted MRI (DW-MRI). Though the correlation was not significant at the whole-brain level (<italic>r</italic> = −0.03, <italic>p</italic> = 0.239, <italic>r</italic> ∈ [−0.12,0.06], <italic>p</italic>_perm = 0.762), change in cortical thickness and disease exposure within the individual hemispheres were significantly correlated. Similar results were observed within the left hemisphere (<italic>r</italic> = 0.14, <italic>p</italic> = 0.016, <italic>r</italic> ∈ [0.01,0.27], <italic>p</italic>_perm = 0.016) and the right hemisphere (<italic>r</italic> = 0.11, <italic>p</italic> = 0.044, <italic>r</italic> ∈ [−0.02,0.25], <italic>p</italic>_perm = 0.041). Failure to capture the relationship at the whole-brain level may be due to inherent limitations in DW-MRI to detect interhemispheric connectivity<sup><xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR33">33</xref></sup> (See Discussion section).</p>
<p id="Par14">For comparison, when only considering pure Euclidean distance, we found that cortical thickness of neither the whole brain (<italic>r</italic> = −0.06, <italic>p</italic> = 0.104, <italic>r</italic> ∈ [−0.15,0.03], <italic>p</italic>_perm = 0.105) nor the left hemisphere (<italic>r</italic> = −0.09, <italic>p</italic> = 0.088, <italic>r</italic> ∈ [−0.22,0.04], <italic>p</italic>_perm = 0.084) correlated with the disease exposure from bilateral-affected regions. However, when only considering the right hemisphere, we observed significant results (<italic>r</italic> = −0.21, <italic>p</italic> = 0.0007, <italic>r</italic> ∈ [−0.33,−0.09], <italic>p</italic>_perm = 0.0006).</p>
<p id="Par15">Furthermore, we tested the relative contribution of functional and structural networks to disease spread using a multivariate model for each hemisphere. Within the left hemisphere, the analysis shows that both functional connectivity (<italic>β</italic> = 0.18, <italic>t</italic>(220) = −3.88, <italic>p</italic> &lt; 0.001) and structural connectivity (<italic>β</italic> = 0.04, <italic>t</italic>(220) = −2.27, <italic>p</italic> = 0.02) significantly relate to cortical atrophy. Within the right hemisphere, again functional connectivity (<italic>β</italic> = 0.12, <italic>t</italic>(220) = −2.56, <italic>p</italic> = 0.01) and structural connectivity (β = 0.08, <italic>t</italic>(220) = −2.77, <italic>p</italic> &lt; 0.01) significantly relate to cortical atrophy. These results suggest that both types of connectivity play a role in the disease-spread model; however, functional connectivity appears to be more significant.</p>
<p id="Par16">As a follow-up exploratory analysis, we tested whether striatal and non-striatal regions within our disease reservoir may contribute differently to disease exposure. Based on functional connectivity, analysis restricted to a basal ganglia reservoir showed an increased effect size within the left hemisphere (<italic>r</italic> = 0.29, <italic>p</italic> &lt; 0.0001, <italic>r</italic> ∈ [0.16,0.40], <italic>p</italic>_perm &lt; 0.0001), right hemisphere (<italic>r</italic> = 0.37, <italic>p</italic> &lt; 0.0001, <italic>r</italic> ∈ [0.26,0.47], <italic>p</italic>_perm &lt; 0.0001), and across the whole rain (<italic>r</italic> = 0.29, <italic>p</italic> &lt; 0.0001, <italic>r</italic> ∈ [0.21,0.37], <italic>p</italic>_perm &lt; 0.0001) compared to the analysis using all affected subcortical regions. When repeating this analysis for structural connectivity, the effect size observed for a basal ganglia-restricted analysis within the left hemisphere (<italic>r</italic> = 0.14, <italic>p</italic> = 0.016, <italic>r</italic> ∈ [0.01,0.27], <italic>p</italic>_perm = 0.017), right hemisphere (<italic>r</italic> = 0.15, <italic>p</italic> = 0.012, <italic>r</italic> ∈ [0.01,0.28], <italic>p</italic>_perm = 0.011), and across the whole brain (<italic>r</italic> = 0.02, <italic>p</italic> = 0.35, <italic>r</italic> ∈ [−0.08,0.11], <italic>p</italic>_perm = 0.35) were similar to the analyses considering all subcortical structures.</p>
</sec>
<sec id="Sec6">
<title>Relation to cognition and cerebrospinal fluid (CSF) measures</title>
<p id="Par17">Additional analyses restricted to the PD group were performed to investigate the relationship between cortical thinning of the four identified clusters and other disease-related measures (Fig. <xref ref-type="fig" rid="Fig5">5</xref>). To test whether CSF measures may contribute to the cortical thinning within each of the clusters, we conducted partial correlations (controlling for age and gender). We found that changes in the left frontal (<italic>r</italic> = −0.16, <italic>p</italic> = 0.05) and left occipital cluster (<italic>r</italic> = −0.18, <italic>p</italic> = 0.037) both correlated negatively with CSF Aβ<sub>42</sub>. Changes of the left occipital cluster (<italic>r</italic> = 0.17, <italic>p = </italic>0.043) also correlated with CSF α-syn. We then performed a linear regression model to examine whether cortical thinning was related to cognitive decline (as assessed by MoCA) and found the overall model, controlling for covariates, was significant (<italic>r</italic>
<sup><italic>2</italic></sup>
<italic> = </italic>0.12, <italic>p</italic> = 0.03). Further post-hoc analysis revealed that only the cortical thinning of the left frontal cluster (<italic>r</italic> = −0.19, <italic>p</italic> = 0.03) significantly related to MoCA changes. Note that these analyses fail to survive correction for multiple comparisons of the four significant clusters.<fig id="Fig5"><label>Fig. 5</label><caption><p>Relation to markers of cognitive decline. <bold>a</bold> Linear regression model between changes (delta) in cortical thickness clusters and cognitive score (MoCA). The overall model was significant; specifically, thinning of the left frontal cluster (<italic>β</italic> = −0.23, <italic>p</italic> = 0.03) and age (β = 0.22, <italic>p</italic> = 0.01) were significantly related to decline in cognitive performance. <bold>b</bold> Partial correlations of CSF Aβ<sub>42</sub> with thinning of each cortical thickness cluster revealed significant correlations in the left hemispheric clusters. All analyses controlled for age and gender</p></caption><graphic id="d29e1752" xlink:href="41467_2017_2416_Fig5_HTML"></graphic></fig>
</p>
<p id="Par18">CSF measures did not correlate with individual time point measures nor changes in MoCA or motor severity as assessed by UPDRS-III (all <italic>p</italic> &gt; 0.05). No significant correlation was observed between cortical thickness of any of the four clusters and measures of UPDRS-III or p-tau<sub>181</sub>. In the control group, no significant correlations between cortical thickness and measures of UPDRS-III, MoCA, or CSF biomarkers were observed.</p>
</sec>
</sec>
<sec id="Sec7" sec-type="discussion">
<title>Discussion</title>
<p id="Par19">The present study investigated 105 PD and 57 control participants over a 1-year period following initial diagnosis. Early PD progression was associated with significant cortical changes. While aging was also associated with cortical thinning, PD patients demonstrated significantly greater reduction in cortical thickness than controls (0.028 mm vs 0.019 mm reduction on average). This was observed mostly in parts of the left occipital and bilateral frontal lobes and right somatomotor-sensory cortex—regions largely belonging to the limbic, frontoparietal, ventral attention, and default mode networks.</p>
<p id="Par20">We tested the theory that neurodegeneration in PD results from a disease-spreading process that enters the cerebral cortex from initially affected subcortical areas. Per the network propagation hypothesis, neurodegenerative diseases result from the aggregation and propagation of misfolded proteins, which in turn results in neuronal death and brain atrophy<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. The distribution of focal cortical thinning should therefore be contingent on connectivity to already affected areas, which we call a “disease reservoir” by analogy to the spread of epidemics in populations. In the present study, we tested this hypothesis in PD with longitudinal data. We found that cortical regions with greater connectivity (measured functionally or structurally) to the subcortical disease reservoir identified at the time of diagnosis demonstrated greater cortical atrophy over the 1-year period. This is in line with our previous work using DBM in the initial scan from this dataset<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, which indicated that regions demonstrating the greatest atrophy were those belonging to a connectivity network with an epicenter in substantia nigra—the hypothesized origin of misfolded protein spread to the supratentorial cerebrum in PD.</p>
<p id="Par21">Some aspects of our model deserve mention. Predictions based on physical distance were similar to topographical distance based on DW-MRI in the right hemisphere. This may be a result of the known distance bias of probabilistic tractography<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> or that the brain is organized such that neuronal connectivity correlates with Euclidean distance<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Resting-state connectivity, however, better predicted atrophy than tractography or topographical distance, thus supporting the notion that connectivity improves our measure of propagation above and beyond consideration of geometrical distance alone. Moreover, there is no described mechanism by which a protein spreads physically through the neuropil. While functional connectivity models fit the data at a whole-brain level, we only observed a relationship between connectivity and thinning in individual hemispheres when using a DW-MRI connectome. This is perhaps due to inherent limitations in DW-MRI to capture interhemispheric connections<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Finally, the disease exposure analysis limited to the basal ganglia only yielded greater effects on cortical thinning than the whole subcortical reservoir model. This might suggest a greater contribution of basal ganglia to cortical propagation, although our results do not unequivocally demonstrate this. Mathematical models of the dynamic spread through brain networks, accounting for factors such as protein accumulation and clearance, have been proposed in recent years for AD<sup><xref ref-type="bibr" rid="CR34">34</xref>–<xref ref-type="bibr" rid="CR36">36</xref></sup>. Such models might be usefully applied to PD.</p>
<p id="Par22">In our post-hoc analysis, greater reduction in cortical thickness of the left frontal cluster in PD over the 1-year period was associated with worsening cognition (as assessed by the MoCA), although the <italic>p</italic>-value of 0.03 would not survive correction for multiple comparisons. This mirrors results from other studies that have similarly found trending results<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. While dementia is rare in early PD, especially as our cohort was selected to exclude dementia at baseline, we still see greater cortical thinning of frontal clusters in the PD group 1-year postdiagnosis. Cortical neuronal degeneration could be occurring earlier in the clinical course of PD than once thought. Although PD is primarily thought of as a movement disorder, it is recognized to be a brain-wide neurodegenerative process that spreads up from brainstem into cortex, as originally suggested by Braak<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>.</p>
<p id="Par23">In this dataset, only cortical thinning of the left frontal cluster related to cognitive decline. Furthermore, thinning in this frontal cluster was weakly related to reduced Aβ<sub>42</sub> at baseline (Fig. <xref ref-type="fig" rid="Fig5">5</xref>). Lower CSF Aβ<sub>42</sub> and α-syn was also associated with occipital thinning, which did not correlate with cognitive decline. The frontal clusters demonstrating greater loss of cortical thickness in PD involved lateral and medial frontal cortex, predominantly in ventral and orbitofrontal areas. These regions of frontal lobe belong to the limbic system, the frontoparietal systems implicated in focused attention, and the DMN implicated in memory retrieval. This pattern of frontal atrophy is similar to that described in a subgroup of AD patients identified by hierarchical clustering<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> and in patients with behavioral variant frontotemporal dementia<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. A notable difference between the pattern of cortical atrophy described here and that commonly seen in AD is the relative absence of more posterior involvement (precuneus, posterior cingulate, and parietal lobe) in our PD cohort. The effect seen here is much more anterior, possibly reflecting the propagation of disease via dopaminergic or frontostriatal projections. Nonetheless, the DMN is also disrupted in AD<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup> and a target of amyloid plaques<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. The anterior DMN may be an avenue through which dementia develops in PD. We note also that, in the Braak model of AD, the initial cortical site of amyloid-β involvement is the ventral frontal cortex<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> and that the observed ventral frontal atrophy pattern in PD shows a high degree of similarity to early Aβ<sub>42</sub> deposition measured by positron emission tomography in AD<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>.</p>
<p id="Par24">While cognitive impairment is a recognized consequence of PD<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, its underlying mechanism is not well understood. Our findings suggest that, in the PD group, higher Aβ<sub>42</sub> deposition in the brain at baseline (indicated by lower CSF Aβ<sub>42</sub> levels<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>) predicted greater cortical thinning of the left frontal cluster over the 1-year period. Though our results are not conclusive, they suggest that Aβ<sub>42</sub> may make the PD brain more susceptible to cortical thinning and, in turn, more prone to cognitive decline. Indeed, recent positron emission tomographic studies have revealed that cortical amyloid deposits are associated, in a dose-dependent manner, with increased risk for cognitive decline in PD<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Additionally, low CSF Aβ<sub>42</sub> has previously been associated with the risk of subsequent dementia in PD<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. These findings provide evidence in favor of potentially overlapping mechanisms for dementia in PD and AD. Previous research found that 28% of PD patients have AD pathological features at postmortem<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. While it can be argued that the findings observed in the present study may be driven by coincidental occurrence of AD, we found that only 5 of the 105 PD subjects met a proposed CSF amyloid-positive criterion<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. A possible alternate explanation is that synergy between Aβ<sub>42</sub> and α-syn deposition promotes cognitive impairment in PD<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Aβ<sub>42</sub> has been found to promote gray matter atrophy in distributed regions of the parietal and frontal lobe in the normal aging brain<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, akin to the atrophy pattern observed in the present study; α-syn may accelerate the neurodegenerative process associated with normal age-related Aβ<sub>42</sub> deposition, especially in regions connected to the PD disease reservoir.</p>
<p id="Par25">The pattern of cortical atrophy in these de novo PD patients may account for the constellation of mood and cognitive deficits that eventually characterize PD dementia. Involvement of the lateral prefrontal cortex and striatum could lead to executive dysfunction. Inferior frontal areas also affected in behavioral variant frontotemporal dementia may be implicated in apathy, compulsive behaviors, changes in personality, and social deficits. Finally, DMN involvement could account for Alzheimer-like memory deficits while degeneration of ventral visual stream areas could explain visual hallucinations. Using the Neurosynth program and database<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, we searched for the terms most often associated in fMRI publications with each anatomical cluster demonstrating atrophy in PD (Fig. <xref ref-type="fig" rid="Fig6">6</xref>). The left occipital–temporal cluster is associated with (visual) motion, observation, perception, and vision. The right somatomotor-sensory cluster is associated with movement. The frontal clusters are associated with expressions related to language and to the terms theory of mind, self, social, mentalizing, and memory. The atrophic regions observed here subserve the cognitive functions that fail in PD dementia.<fig id="Fig6"><label>Fig. 6</label><caption><p>Functional anatomy of cortical thinning in PD. Peaks within each cluster were associated with expressions used in publications using Neurosynth. The <italic>x</italic> axes represent correlation values between the cluster and each concept’s meta-analytic map generated using seed-based networks. The <italic>y</italic> axes represent the most highly correlated concepts per cluster</p></caption><graphic id="d29e1939" xlink:href="41467_2017_2416_Fig6_HTML"></graphic></fig>
</p>
<p id="Par26">Findings from this study should be considered in light of some limitations. While the cellular events leading to changes in cortical thickness are not clear, cortical thickness as measured with T1-weighted MRI is nonetheless believed to reflect neuronal density along with glial support and dendritic arborization<sup><xref ref-type="bibr" rid="CR53">53</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>. In PD, reductions in cortical thickness most likely reflect neurodegeneration. In the current paper, we address the “protein-spread” model, which we note remains controversial and lacking in supportive human evidence<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. With our current dataset and imaging modalities, we cannot rule out the possibility of a stochastic attack on the brain as a whole that would give the appearance of network spread. Areas that are connected could share features (e.g., gene expression<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>) that make them similarly vulnerable to a specific pathophysiological process. In this case, the map of atrophy would look like a network but not be driven by connectivity. Additionally, neurodegeneration could propagate due to loss of trophic factors having nothing to do with misfolded protein spread. Moreover, we cannot measure α-syn accumulation but only its consequence (cortical thinning), and the two may have a complex and nonlinear relationship. However, the present finding that a connectivity model explains disease progression better than chance lends support to the network-propagation hypothesis. The inclusion criterion of MoCA &gt; 26 may have biased both the PD and HC pool. Also, while our sample is relatively large, the PPMI sample is a research-based cohort and may not be truly representative of a population-based cohort. Finally, most patients were prescribed dopaminergic treatments after diagnosis, which may mask the magnitude of cognitive decline and motor symptoms and their relationship with brain atrophy. Future longitudinal studies and follow-up with patients at later stages of the disease as well as postmortem confirmation are needed to understand the relationship between cortical atrophy and the underlying disease process.</p>
<p id="Par27">The current study is the largest to date to assess longitudinal measures of cortical thickness using 3 T MRI in a de novo PD cohort. Our findings suggest that disease propagation to the cortex occurs earlier than previously thought. Focal cortical thinning may be contingent on connectivity to a disease reservoir: the greater the connections, the higher the disease exposure, and the more the cortical atrophy. PD progression involves subcortical α-syn spreading through intrinsic brain networks to the cortex, possibly in synergy with Aβ<sub>42</sub>, which may be the harbinger of cognitive decline.</p>
</sec>
<sec id="Sec8" sec-type="materials|methods">
<title>Methods</title>
<p id="Par28">The PD patients included in this study met the PPMI inclusion criteria<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> consisting of asymmetric resting tremor or asymmetric bradykinesia or any two of bradykinesia, resting tremor, and limb rigidity. Patients had to have been diagnosed within 2 years of enrollment and not have received anti-parkinsonian medications. Diagnosis was confirmed with dopamine transporter imaging using single-photon emission computed tomography. Control subjects were free of neurological disease. Each participating PPMI site received approval from their local institutional review board and obtained written informed consent from all subjects. Analysis of this dataset was approved by the Montreal Neurological Institute Research Ethics Board. Only participants with 3 T MRI data at both initial visit and 1-year follow-up were included in the present study. Of the 237 PD patients with 3 T acquisition at baseline, 122 had MRI data at the 1-year follow-up. For controls, 118 subjects had 3 T acquisition at baseline, and 62 had MRI data at the 1-year follow-up.</p>
<p id="Par29">All non-categorical data were normally distributed as per Shapiro–Wilk tests. Group difference in sociodemographic and neuropsychological variables were analyzed using the χ<sup>2</sup> test for categorical data and <italic>t</italic>-test for normally distributed data.</p>
<sec id="Sec9">
<title>MRI acquisition</title>
<p id="Par30">T1-weighted MRI scans were acquired in the sagittal plane on 3 T scanners at each study site using a magnetization-prepared rapid-acquisition gradient echo sequence (full study protocol: <ext-link ext-link-type="uri" xlink:href="http://www.ppmi-info.org/study-design/research-documents-and-sops/">http://www.ppmi-info.org/study-design/research-documents-and-sops/</ext-link>). Acquisition parameters were as follows: repetition time = 2300/1900 ms; echo time = 2.98/2.96/2.27/2.48/2.52 ms; inversion time = 900 ms; flip angle: 9°; 256 × 256 matrix; and 1 × 1 × 1 mm<sup>3</sup> isotropic voxel. Acquisition site was used as a covariate in all analyses.</p>
</sec>
<sec id="Sec10">
<title>Cortical thickness</title>
<p id="Par31">Cortical thickness models were generated from the T1-weighted 3 T MRI scans using the CIVET2.1 preprocessing pipeline<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. A summary of the steps involved follows; full documentation can be found online (<ext-link ext-link-type="uri" xlink:href="http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET">http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET</ext-link>). The T1-weighted MRIs were linearly registered to the MNI-ICBM152 volumetric template<sup><xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. Images were then corrected for signal intensity non-uniformity<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>, and a brain mask was calculated from each input image. Images were then segmented into gray matter, white matter, CSF, and background<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. After the CIVET pipeline, quality control was carried out by two independent reviewers using previously described criteria<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> to ensure adequate quality of the T1-wieghted volume images, such as linear and nonlinear registration, and to exclude distortions in gray and white matter surfaces and motion artifacts. Seventeen of the 122 PD and 5 of the 62 HC failed quality control.</p>
<p id="Par32">The distance between the corresponding vertices of inner and outer cortical surfaces were evaluated by a fully automated method (Constrained Laplacian Anatomic Segmentation using Proximity algorithm<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>) to provide a measure of cortical thickness at each vertex. The white and gray matter interface was fitted across 40,692 vertices in each hemisphere to create the inner cortical surface, then expanded to fit the gray matter and CSF interface to create the outer cortical surface. The surfaces of each subject were nonlinearly registered to an average surface created from the volumetric ICBM152 template. In order to test the propagation hypothesis, the brain was segmented into 448 cortical and 15 subcortical regions<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, and each of the 40,692 cortical vertices from the cortical thickness analysis was interpolated and assigned to one of the 448 cortical parcels.</p>
<p id="Par33">Changes in cortical thickness were calculated by subtracting the values (Δ<italic>t = t</italic>
<sub>1</sub>
<italic>−t</italic>
<sub>2</sub>) at the 1-year follow-up (<italic>t</italic>
<sub>2</sub>) from the baseline (<italic>t</italic>
<sub>1</sub>) for both groups using the SurfStat software package (<ext-link ext-link-type="uri" xlink:href="http://www.math.mcgill.ca/keith/surfstat/">http://www.math.mcgill.ca/keith/surfstat/</ext-link>). Difference between PD and controls [(PD<sub>1</sub>-PD<sub>2</sub>)–(HC<sub>1</sub>-HC<sub>2</sub>)] were analyzed statistically based on random field theory with a threshold of <italic>p</italic> &lt; 0.05 corrected for multiple comparisons over the entire cortical surface<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>.</p>
<p id="Par34">In order to address the relationship between cognitive decline and cortical thinning over the 1-year period, we performed a linear regression model. Change in MoCA was the dependent variable, while mean cortical thinning values from each of the four clusters distinguishing PD from controls were the independent variables. Gender and age at baseline were used as covariates. Observed differences in cortical thickness were then correlated to other potential disease-related measures (i.e., UPDRS-III, MoCA, CSF α-syn, and tau and Aβ<sub>42</sub> markers) using Pearson partial correlations as post-hoc analysis. All the analyses were performed using MatLab 2015b statistics toolbox. Within PD patients, the difference in cognitive performance over the 1-year interval was examined using a linear regression model with MoCA as the dependent variable and the thinning of the four cortical clusters as independent variables.</p>
<p id="Par35">To test whether cortical thickness of a specific cluster was linked to cognitive performance, post-hoc analyses using partial correlations were conducted. Age at baseline and gender were used as confounding covariates for all analyses including for partial correlations, linear regression model, and for obtaining cortical thickness.</p>
</sec>
<sec id="Sec11">
<title>Deformation-based morphometry</title>
<p id="Par36">Data were analyzed from the baseline visits of newly diagnosed PD patients (<italic>n</italic> = 232) and an age-matched control group (<italic>n</italic> = 117) obtained from the PPMI database. All subjects’ initial visit's 3 T high-resolution T1-weighted MRI scans underwent preprocessing steps including denoising<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, intensity non-uniformity correction<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>, and intensity range normalization. Next, each subject’s T1-weighted image was first linearly, and then nonlinearly, registered to the MNI-ICBM152 template. Using the resulting nonlinear transformation fields, we calculated deformation morphometry maps (i.e., the determinant of the Jacobian matrix of transformation). DBM maps were then concatenated and independent component analysis (ICA) was employed to define independent sources of deformation in the brain. For the resulting ICA components (<italic>n</italic> = 30), the PD group was compared to healthy controls (unpaired <italic>t</italic>-test). The atrophy level significantly differed between PD and control groups in only one of these components after correcting for multiple comparisons (Bonferroni correction), suggesting that this component captures PD-specific alterations in the brain. We used this component (referred to as PD-ICA here) as our atrophy map. The component score (atrophy measure) in PD-ICA for each subject was significantly correlated with disease severity as measured by UPDRS-III and single-photon emission computed tomography striatum binding ratio. Please see Zeighami et al.<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> for further details.</p>
</sec>
<sec id="Sec12">
<title>Connectivity and disease propagation</title>
<p id="Par37">The difference in cortical thinning in PD vs controls was used to define disease progression. DBM on the baseline MRI was employed to assess disease-related brain atrophy and to define a source, or reservoir, for disease propagation. Based on a parcellation that is a subdivision of the common FreeSurfer implementation of the Desikan–Killiany Atlas, gray matter was segmented into 463 regions of interest of approximately similar size<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Of these parcels, 448 were cortical and 15 were subcortical (thalamus, caudate, putamen, pallidum, accumbens, hippocampus, amygdala in each hemisphere and brainstem). Each surface vertex from the cortical thickness analysis was then mapped to the corresponding nearest whole-brain parcel from the Atlas. The “disease reservoir” was defined as the 15 subcortical parcels from the Atlas, and the Atrophy value at each parcel was obtained from the DBM map.</p>
<p id="Par38">To generate brain networks and connectomes, data-driven brain parcellations from young healthy individuals were used<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. The functional connectivity map was derived from resting-state fMRI data of 40 young healthy subjects (25.3 ± 4.9 years, 24 males)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. The scans were done using Siemens Medical Trio 3 T MRI scanner, consisting of a high-resolution T1-weighted image, as well as T2*-weighted images with blood-oxygen-level-dependent contrast (3.3 mm<sup>3</sup> isotropic voxels, TR 1.9 s). The dataset was preprocessed using conventional steps consisting of rigid body motion correction, correcting for nuisance variables (white matter, CSF, motion parameters), and low pass filtering. The structural connectivity map was generated using the Illinois Institute of Technology Human Brain Atlas v.3, (freely available at <ext-link ext-link-type="uri" xlink:href="http://www.iit.edu/~mri/Home.html">http://www.iit.edu/~mri/Home.html</ext-link>). The atlas was constructed using data from 72 neurologically healthy subjects (20–40 years, 28.8 ± 5.5 years, 30 males). All subjects were scanned using a 3 T General Electric MRI scanner (GE, Waukesha, WI) with the following parameters (TR = 5800 ms, TE = 94ms, voxel size = 3 mm<sup>3</sup>, 256 × 256 final image matrix, FoV = 24 × 24 cm<sup>2</sup>, <italic>b</italic> = 900 s mm<sup>−2</sup>, 45 slices for 12 diffusion directions uniformly distributed in 3D space, scan time: 21 min 57 s)<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. Imposing a maximum of 500 mm trace length and a curvature threshold of ±90, the anatomical connection probability was calculated between all pairs of regions using a probabilistic graph-based tractography algorithm<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>.</p>
<p id="Par39">Spearman’s correlation was used to investigate the relationship between disease progression in cortical areas (cortical thinning) and the ‘disease exposure’ for each region in the PD-ICA (defined by the average values of each region weighted by connectivity). The same procedure was performed to test propagation hypotheses along the functional and structural connectomes. The propagation analysis was performed for the whole brain and for each hemisphere separately.</p>
</sec>
<sec id="Sec13">
<title>CSF measures</title>
<p id="Par40">CSF Aβ<sub>42</sub>, α-syn, t-tau, and p-tau<sub>181</sub> were collected by lumbar puncture at PPMI clinical sites<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. Frozen aliquots (at −80 °C) were then shipped and assessed using the MAP Luminex platform (Luminex Corp, Austin, TX) with Innogenetics (INNO-BIA AlzBio3; Ghent, Belgium; for research use-only reagents) immunoassays used for Aβ<sub>42</sub>, t-tau and p-tau<sub>181</sub>. CSF α-syn assay was performed at Covance using a commercially available ELISA Assay Kit (Covance, Dedham, MA)<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. To evaluate the possible contamination of blood in CSF—a factor thought to influence the level of some proteins including α-syn and Aβ<sub>42</sub>
<sup><xref ref-type="bibr" rid="CR69">69</xref>,<xref ref-type="bibr" rid="CR70">70</xref></sup>—the relationship between CSF hemoglobin and other CSF measures was assessed. No significant association was observed (all <italic>p</italic> &lt; 0.05), suggesting that there is no effect of added blood on concentration of CSF measures. Owing to the ongoing nature of the study and incomplete data, only CSF data from baseline were used in this analysis<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>.</p>
</sec>
<sec id="Sec14">
<title>Code availability</title>
<p id="Par41">All code written by the authors of this manuscript is available upon request.</p>
</sec>
<sec id="Sec15">
<title>Data availability</title>
<p id="Par42">The DBM maps are available at <ext-link ext-link-type="uri" xlink:href="https://neurovault.org/collections/860/">https://neurovault.org/collections/860/</ext-link>. Cortical thickness maps will be made available on request. The CIVET pipeline is available at <ext-link ext-link-type="uri" xlink:href="http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET">http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET</ext-link>. The functional and structural connectome data are from cited sources and available upon request from the authors of the related publications.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec16">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2017_2416_MOESM1_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>Y. Yau and Y. Zeighami contributed equally to this work.</p>
</fn>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>
<bold>Supplementary Information</bold> accompanies this paper at 10.1038/s41467-017-02416-0.</p>
</fn>
<fn>
<p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>PPMI—a public–private partnership—is funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners, including AbbVie, Avid, Biogen, Bristol-Myers Squibb, Covance, GE Healthcare, Genentech, GlaxoSmithKline, Lilly, Lundbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Sanofi Genzyme, Servier, Teva, and UCB. This research was supported by grants from the Michael J. Fox Foundation for Parkinson’s Research, the W. Garfield Weston Foundation, and the Alzheimer’s Association; the Canadian Institutes of Health Research; and the Natural Sciences and Engineering Research Council of Canada to A.D. Y.Y. is a Vanier Scholar and receives funding from the Canadian Institute of Health Research. Y.Z. holds the Jeanne Timmins Costello Fellowship.</p>
</ack>
<notes notes-type="author-contribution">
<title>Author contributions</title>
<p>Y.Y., Y.Z., and A.D. contributed to the study design and interpretation. Y.Y., Y.Z., T.B., K.L., U.V., and M.D. analyzed the data. V.F., B.M., D.L.C., P.H., and A.G. contributed to methods. Y.Y. drafted the initial manuscript; all authors contributed to writing of this manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Competing interests</title>
<p id="Par43">The authors declare no competing financial interests.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Neurodegenerative diseases target large-scale human brain networks</article-title>
<source/>Neuron
          <year>2009</year>
<volume>62</volume>
<fpage>42</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.03.024</pub-id>
<pub-id pub-id-type="pmid">19376066</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular nexopathies: a new paradigm of neurodegenerative disease</article-title>
<source/>Trends Neurosci.
          <year>2013</year>
<volume>36</volume>
<fpage>561</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2013.06.007</pub-id>
<pub-id pub-id-type="pmid">23876425</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burre</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro</article-title>
<source/>Science
          <year>2010</year>
<volume>329</volume>
<fpage>1663</fpage>
<lpage>1667</lpage>
<pub-id pub-id-type="doi">10.1126/science.1195227</pub-id>
<pub-id pub-id-type="pmid">20798282</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luk</surname>
<given-names>KC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice</article-title>
<source/>Science
          <year>2012</year>
<volume>338</volume>
<fpage>949</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="doi">10.1126/science.1227157</pub-id>
<pub-id pub-id-type="pmid">23161999</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Staging of brain pathology related to sporadic Parkinson’s disease</article-title>
<source/>Neurobiol. Aging
          <year>2003</year>
<volume>24</volume>
<fpage>197</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1016/S0197-4580(02)00065-9</pub-id>
<pub-id pub-id-type="pmid">12498954</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2016</year>
<volume>17</volume>
<fpage>251</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1038/nrn.2016.13</pub-id>
<pub-id pub-id-type="pmid">26988744</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surmeier</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Obeso</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Halliday</surname>
<given-names>GM</given-names>
</name>
</person-group>
<article-title>Selective neuronal vulnerability in Parkinson disease</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2017</year>
<volume>18</volume>
<fpage>101</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1038/nrn.2016.178</pub-id>
<pub-id pub-id-type="pmid">28104909</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marek</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Parkinson Progression Marker Initiative (PPMI)</article-title>
<source/>Prog. Neurobiol.
          <year>2011</year>
<volume>95</volume>
<fpage>629</fpage>
<lpage>635</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2011.09.005</pub-id>
<pub-id pub-id-type="pmid">21930184</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeighami</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Network structure of brain atrophy in de novo Parkinson’s disease</article-title>
<source/>eLife
          <year>2015</year>
<volume>4</volume>
<fpage>e08440</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.08440</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reetz</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural imaging in the presymptomatic stage of genetically determined parkinsonism</article-title>
<source/>Neurobiol. Dis.
          <year>2010</year>
<volume>39</volume>
<fpage>402</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2010.05.006</pub-id>
<pub-id pub-id-type="pmid">20483373</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fioravanti</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MRI correlates of Parkinson’s disease progression: a voxel based morphometry study</article-title>
<source/>Parkinsons Dis.
          <year>2015</year>
<volume>2015</volume>
<fpage>8</fpage>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camicioli</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism</article-title>
<source/>Parkinsonism Relat. Disord.
          <year>2009</year>
<volume>15</volume>
<fpage>187</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2008.05.002</pub-id>
<pub-id pub-id-type="pmid">18573676</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menke</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comprehensive morphometry of subcortical grey matter structures in early‐stage Parkinson’s disease</article-title>
<source/>Hum. Brain Mapp.
          <year>2014</year>
<volume>35</volume>
<fpage>1681</fpage>
<lpage>1690</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.22282</pub-id>
<pub-id pub-id-type="pmid">23861334</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davatzikos</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Why voxel-based morphometric analysis should be used with great caution when characterizing group differences</article-title>
<source/>Neuroimage
          <year>2004</year>
<volume>23</volume>
<fpage>17</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.05.010</pub-id>
<pub-id pub-id-type="pmid">15325347</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Draganski</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ashburner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weiskopf</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging</article-title>
<source/>Neuroimage
          <year>2009</year>
<volume>48</volume>
<fpage>371</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.06.043</pub-id>
<pub-id pub-id-type="pmid">19559801</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>JB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Assessment of cortical degeneration in patients with Parkinson’s disease by voxel-based morphometry, cortical folding, and cortical thickness</article-title>
<source/>Hum. Brain Mapp.
          <year>2012</year>
<volume>33</volume>
<fpage>2521</fpage>
<lpage>2534</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.21378</pub-id>
<pub-id pub-id-type="pmid">21898679</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khundrakpam</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Kostopoulos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carbonell</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Cortical thickness abnormalities in autism spectrum disorders through late childhood, adolescence, and adulthood: a large-scale MRI study</article-title>
<source/>Cereb. Cortex
          <year>2017</year>
<volume>27</volume>
<fpage>1721</fpage>
<lpage>1731</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhx038</pub-id>
<pub-id pub-id-type="pmid">28334080</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickerson</surname>
<given-names>BC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The cortical signature of Alzheimer’s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals</article-title>
<source/>Cereb. Cortex
          <year>2009</year>
<volume>19</volume>
<fpage>497</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhn113</pub-id>
<pub-id pub-id-type="pmid">18632739</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibarretxe-Bilbao</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Progression of cortical thinning in early Parkinson’s disease</article-title>
<source/>Mov. Disord.
          <year>2012</year>
<volume>27</volume>
<fpage>1746</fpage>
<lpage>1753</lpage>
<pub-id pub-id-type="doi">10.1002/mds.25240</pub-id>
<pub-id pub-id-type="pmid">23124622</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jubault</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patterns of cortical thickness and surface area in early Parkinson’s disease</article-title>
<source/>Neuroimage
          <year>2011</year>
<volume>55</volume>
<fpage>462</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.12.043</pub-id>
<pub-id pub-id-type="pmid">21184830</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarei</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cortical thinning is associated with disease stages and dementia in Parkinson’s disease</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2013</year>
<volume>84</volume>
<fpage>875</fpage>
<lpage>882</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp-2012-304126</pub-id>
<pub-id pub-id-type="pmid">23463873</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>JB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Initial cognitive decline is associated with cortical thinning in early Parkinson disease</article-title>
<source/>Neurology
          <year>2014</year>
<volume>82</volume>
<fpage>2017</fpage>
<lpage>2025</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000000483</pub-id>
<pub-id pub-id-type="pmid">24808018</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hely</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Adena</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Halliday</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years</article-title>
<source/>Mov. Disord.
          <year>2008</year>
<volume>23</volume>
<fpage>837</fpage>
<lpage>844</lpage>
<pub-id pub-id-type="doi">10.1002/mds.21956</pub-id>
<pub-id pub-id-type="pmid">18307261</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aarsland</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cognitive decline in Parkinson disease</article-title>
<source/>Nat. Rev. Neurol.
          <year>2017</year>
<volume>13</volume>
<fpage>217</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2017.27</pub-id>
<pub-id pub-id-type="pmid">28257128</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dirnberger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jahanshahi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Executive dysfunction in Parkinson’s disease: a review</article-title>
<source/>J. Neuropsychol.
          <year>2013</year>
<volume>7</volume>
<fpage>193</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1111/jnp.12028</pub-id>
<pub-id pub-id-type="pmid">24007368</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Callesen</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Weintraub</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Damholdt</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Impulsive and compulsive behaviors among Danish patients with Parkinson’s disease: prevalence, depression, and personality</article-title>
<source/>Parkinsonism Relat. Disord.
          <year>2014</year>
<volume>20</volume>
<fpage>22</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2013.09.006</pub-id>
<pub-id pub-id-type="pmid">24090948</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ffytche</surname>
<given-names>DH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The psychosis spectrum in Parkinson disease</article-title>
<source/>Nat. Rev. Neurol.
          <year>2017</year>
<volume>13</volume>
<fpage>81</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2016.200</pub-id>
<pub-id pub-id-type="pmid">28106066</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeo</surname>
<given-names>BT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The organization of the human cerebral cortex estimated by intrinsic functional connectivity</article-title>
<source/>J. Neurophysiol.
          <year>2011</year>
<volume>106</volume>
<fpage>1125</fpage>
<lpage>1165</lpage>
<pub-id pub-id-type="doi">10.1152/jn.00338.2011</pub-id>
<pub-id pub-id-type="pmid">21653723</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cammoun</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mapping the human connectome at multiple scales with diffusion spectrum MRI</article-title>
<source/>J. Neurosci. Methods
          <year>2012</year>
<volume>203</volume>
<fpage>386</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneumeth.2011.09.031</pub-id>
<pub-id pub-id-type="pmid">22001222</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neher</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Descoteaux</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Houde</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Stieltjes</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Maier-Hein</surname>
<given-names>KH</given-names>
</name>
</person-group>
<article-title>Strengths and weaknesses of state of the art fiber tractography pipelines—a comprehensive in-vivo and phantom evaluation study using tractometer</article-title>
<source/>Med. Image Anal.
          <year>2015</year>
<volume>26</volume>
<fpage>287</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1016/j.media.2015.10.011</pub-id>
<pub-id pub-id-type="pmid">26599155</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jbabdi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sotiropoulos</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Haber</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Van Essen</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Behrens</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>Measuring macroscopic brain connections in vivo</article-title>
<source/>Nat. Neurosci.
          <year>2015</year>
<volume>18</volume>
<fpage>1546</fpage>
<lpage>1555</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4134</pub-id>
<pub-id pub-id-type="pmid">26505566</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ercsey-Ravasz</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A predictive network model of cerebral cortical connectivity based on a distance rule</article-title>
<source/>Neuron
          <year>2013</year>
<volume>80</volume>
<fpage>184</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.036</pub-id>
<pub-id pub-id-type="pmid">24094111</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Knosche</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>White matter integrity, fiber count, and other fallacies: the do’s and don’ts of diffusion MRI</article-title>
<source/>Neuroimage
          <year>2013</year>
<volume>73</volume>
<fpage>239</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.06.081</pub-id>
<pub-id pub-id-type="pmid">22846632</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raj</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuceyeski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A network diffusion model of disease progression in dementia</article-title>
<source/>Neuron
          <year>2012</year>
<volume>73</volume>
<fpage>1204</fpage>
<lpage>1215</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.12.040</pub-id>
<pub-id pub-id-type="pmid">22445347</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iturria-Medina</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sotero</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Toussaint</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Alzheimer’s Disease Neuroimaging Initiative</surname>
</name>
</person-group>
<article-title>Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders</article-title>
<source/>PLoS Comput. Biol.
          <year>2014</year>
<volume>10</volume>
<fpage>e1003956</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1003956</pub-id>
<pub-id pub-id-type="pmid">25412207</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gennatas</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</name>
</person-group>
<article-title>Predicting regional neurodegeneration from the healthy brain functional connectome</article-title>
<source/>Neuron
          <year>2012</year>
<volume>73</volume>
<fpage>1216</fpage>
<lpage>1227</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.004</pub-id>
<pub-id pub-id-type="pmid">22445348</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caspell-Garcia</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<fpage>e0175674</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0175674</pub-id>
<pub-id pub-id-type="pmid">28520803</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Pathoanatomy of Parkinson’s disease</article-title>
<source/>J. Neurol.
          <year>2000</year>
<volume>247</volume>
<fpage>II3</fpage>
<lpage>II10</lpage>
<pub-id pub-id-type="doi">10.1007/PL00007758</pub-id>
<pub-id pub-id-type="pmid">10991663</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prediction of Alzheimer’s disease pathophysiology based on cortical thickness patterns</article-title>
<source/>Alzheimers Dement. (Amst.)
          <year>2016</year>
<volume>2</volume>
<fpage>58</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">27239533</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2004</year>
<volume>101</volume>
<fpage>4637</fpage>
<lpage>4642</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0308627101</pub-id>
<pub-id pub-id-type="pmid">15070770</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
          <year>2012</year>
<volume>33</volume>
<fpage>466</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2010.04.013</pub-id>
<pub-id pub-id-type="pmid">20541837</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheline</surname>
<given-names>YI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly</article-title>
<source/>Biol. Psychiatry
          <year>2010</year>
<volume>67</volume>
<fpage>584</fpage>
<lpage>587</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.08.024</pub-id>
<pub-id pub-id-type="pmid">19833321</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Frequency of stages of Alzheimer-related lesions in different age categories</article-title>
<source/>Neurobiol. Aging
          <year>1997</year>
<volume>18</volume>
<fpage>351</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1016/S0197-4580(97)00056-0</pub-id>
<pub-id pub-id-type="pmid">9330961</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villain</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study</article-title>
<source/>Brain
          <year>2012</year>
<volume>135</volume>
<fpage>2126</fpage>
<lpage>2139</lpage>
<pub-id pub-id-type="doi">10.1093/brain/aws125</pub-id>
<pub-id pub-id-type="pmid">22628162</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmqvist</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography</article-title>
<source/>JAMA Neurol.
          <year>2014</year>
<volume>71</volume>
<fpage>1282</fpage>
<lpage>1289</lpage>
<pub-id pub-id-type="doi">10.1001/jamaneurol.2014.1358</pub-id>
<pub-id pub-id-type="pmid">25155658</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomperts</surname>
<given-names>SN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PET radioligands reveal the basis of dementia in Parkinson’s disease and dementia with Lewy bodies</article-title>
<source/>Neurodegener. Dis.
          <year>2016</year>
<volume>16</volume>
<fpage>118</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1159/000441421</pub-id>
<pub-id pub-id-type="pmid">26655867</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CSF Aβ42 predicts early-onset dementia in Parkinson disease</article-title>
<source/>Neurology
          <year>2014</year>
<volume>82</volume>
<fpage>1784</fpage>
<lpage>1790</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000000425</pub-id>
<pub-id pub-id-type="pmid">24748671</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irwin</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuropathologic substrates of Parkinson disease dementia</article-title>
<source/>Ann. Neurol.
          <year>2012</year>
<volume>72</volume>
<fpage>587</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="doi">10.1002/ana.23659</pub-id>
<pub-id pub-id-type="pmid">23037886</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMillan</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Wolk</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson’s disease</article-title>
<source/>J. Neurol.
          <year>2016</year>
<volume>87</volume>
<fpage>1112</fpage>
<lpage>1122</lpage>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frey</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Petrou</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes</article-title>
<source/>Clin. Transl. Imaging
          <year>2015</year>
<volume>3</volume>
<fpage>57</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1007/s40336-015-0104-4</pub-id>
<pub-id pub-id-type="pmid">25745616</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sepulcre</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vivo tau, amyloid, and gray matter profiles in the aging brain</article-title>
<source/>J. Neurosci.
          <year>2016</year>
<volume>36</volume>
<fpage>7364</fpage>
<lpage>7374</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0639-16.2016</pub-id>
<pub-id pub-id-type="pmid">27413148</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yarkoni</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Poldrack</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Van Essen</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Wager</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Large-scale automated synthesis of human functional neuroimaging data</article-title>
<source/>Nat. Methods
          <year>2011</year>
<volume>8</volume>
<fpage>665</fpage>
<lpage>670</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.1635</pub-id>
<pub-id pub-id-type="pmid">21706013</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chklovskii</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Mel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Svoboda</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Cortical rewiring and information storage</article-title>
<source/>Nature
          <year>2004</year>
<volume>431</volume>
<fpage>782</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="doi">10.1038/nature03012</pub-id>
<pub-id pub-id-type="pmid">15483599</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>la Fougère</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET</article-title>
<source/>Neuroimage
          <year>2011</year>
<volume>56</volume>
<fpage>951</fpage>
<lpage>960</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.11.015</pub-id>
<pub-id pub-id-type="pmid">21073964</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richiardi</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Correlated gene expression supports synchronous activity in brain networks</article-title>
<source/>Science
          <year>2015</year>
<volume>348</volume>
<fpage>1241</fpage>
<lpage>1244</lpage>
<pub-id pub-id-type="doi">10.1126/science.1255905</pub-id>
<pub-id pub-id-type="pmid">26068849</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<mixed-citation publication-type="other">Ad-Dab’bagh, Y. et al. The CIVET image-processing environment: a fully automated comprehensive pipeline for anatomical neuroimaging research. In <italic>Proc. Organization for Human Brain Mapping</italic> (2006).</mixed-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonov</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>McKinstry</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Almli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Unbiased nonlinear average age-appropriate brain templates from birth to adulthood</article-title>
<source/>Neuroimage
          <year>2009</year>
<volume>47</volume>
<fpage>S102</fpage>
<pub-id pub-id-type="doi">10.1016/S1053-8119(09)70884-5</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonov</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Unbiased average age-appropriate atlases for pediatric studies</article-title>
<source/>Neuroimage
          <year>2011</year>
<volume>54</volume>
<fpage>313</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.07.033</pub-id>
<pub-id pub-id-type="pmid">20656036</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sled</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Zijdenbos</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>A nonparametric method for automatic correction of intensity nonuniformity in MRI data</article-title>
<source/>IEEE Trans. Med. Imaging
          <year>1998</year>
<volume>17</volume>
<fpage>87</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1109/42.668698</pub-id>
<pub-id pub-id-type="pmid">9617910</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simmons</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The AddNeuroMed framework for multi‐centre MRI assessment of Alzheimer’s disease: experience from the first 24 months</article-title>
<source/>Int. J. Geriatr. Psychiatry
          <year>2011</year>
<volume>26</volume>
<fpage>75</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1002/gps.2491</pub-id>
<pub-id pub-id-type="pmid">21157852</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification</article-title>
<source/>Neuroimage
          <year>2005</year>
<volume>27</volume>
<fpage>210</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2005.03.036</pub-id>
<pub-id pub-id-type="pmid">15896981</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worsley</surname>
<given-names>KJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A unified statistical approach for determining significant signals in images of cerebral activation</article-title>
<source/>Hum. Brain Mapp.
          <year>1996</year>
<volume>4</volume>
<fpage>58</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1097-0193(1996)4:1&lt;58::AID-HBM4&gt;3.0.CO;2-O</pub-id>
<pub-id pub-id-type="pmid">20408186</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coupé</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An optimized blockwise nonlocal means denoising filter for 3-D magnetic resonance images</article-title>
<source/>IEEE Trans. Med. Imaging
          <year>2008</year>
<volume>27</volume>
<fpage>425</fpage>
<lpage>441</lpage>
<pub-id pub-id-type="doi">10.1109/TMI.2007.906087</pub-id>
<pub-id pub-id-type="pmid">18390341</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mišić</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cooperative and competitive spreading dynamics on the human connectome</article-title>
<source/>Neuron
          <year>2015</year>
<volume>86</volume>
<fpage>1518</fpage>
<lpage>1529</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.05.035</pub-id>
<pub-id pub-id-type="pmid">26087168</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varentsova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arfanakis</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Development of a high angular resolution diffusion imaging human brain template</article-title>
<source/>Neuroimage
          <year>2014</year>
<volume>91</volume>
<fpage>177</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.01.009</pub-id>
<pub-id pub-id-type="pmid">24440528</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iturria-Medina</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterizing brain anatomical connections using diffusion weighted MRI and graph theory</article-title>
<source/>Neuroimage
          <year>2007</year>
<volume>36</volume>
<fpage>645</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.02.012</pub-id>
<pub-id pub-id-type="pmid">17466539</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Chen-Plotkin</surname>
<given-names>AS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of cerebrospinal fluid β-amyloid 1-42, t-tau, p-tau181, and α-synuclein levels with clinical features of drug-naive patients with early parkinson disease</article-title>
<source/>JAMA Neurol.
          <year>2013</year>
<volume>70</volume>
<fpage>1277</fpage>
<lpage>1287</lpage>
<pub-id pub-id-type="pmid">23979011</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mollenhauer</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Total CSF alpha-synuclein is lower in de novo Parkinson patients than in healthy subjects</article-title>
<source/>Neurosci. Lett.
          <year>2013</year>
<volume>532</volume>
<fpage>44</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2012.11.004</pub-id>
<pub-id pub-id-type="pmid">23149132</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjerke</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Confounding factors influencing amyloid beta concentration in cerebrospinal fluid</article-title>
<source/>Int. J. Alzheimers Dis.
          <year>2010</year>
<volume>2010</volume>
<fpage>986310</fpage>
<pub-id pub-id-type="pmid">20798852</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease</article-title>
<source/>Brain
          <year>2010</year>
<volume>133</volume>
<fpage>713</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awq008</pub-id>
<pub-id pub-id-type="pmid">20157014</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>